(Q47377858)

15 January 2018

title

Final height in short polytransfused thalassemia major patients treated with recombinant growth hormone (English)

1 reference

15 January 2018

1 reference

8

1 reference

15 January 2018

author name string

L Cavallo

1

1 reference

15 January 2018

V De Sanctis

2

1 reference

15 January 2018

M Cisternino

3

1 reference

15 January 2018

M Caruso Nicoletti

4

1 reference

15 January 2018

M C Galati

5

1 reference

15 January 2018

A Acquafredda

6

1 reference

15 January 2018

C Zecchino

7

1 reference

15 January 2018

publication date

1 April 2005

1 reference

15 January 2018

Journal of Endocrinological Investigation

published in

1 reference

15 January 2018

volume

28

1 reference

15 January 2018

issue

4

1 reference

15 January 2018

page(s)

363-366

1 reference

15 January 2018

https://scigraph.springernature.com/pub.10.1007/bf03347204

exact match

0 references

cites work

Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty

1 reference

https://api.crossref.org/works/10.1007%2FBF03347204

Growth deficiency in polytransfused beta-thalassaemia patients is not growth hormone dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347204

Serum growth hormone (GH) binding protein, IGF-I and IGFBP-3 in patients with beta-thalassaemia major and the effect of GH treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347204

Treatment with biosynthetic growth hormone of short thalassaemic patients with impaired growth hormone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347204

Growth hormone treatment of short Chinese children with beta-thalassaemia major without GH deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347204

Growth and puberty and its management in thalassaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347204

Growth hormone (GH) deficiency in patients with beta-thalassemia major and the efficacy of recombinant GH treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03347204

Growth hormone treatment in short children with beta-thalassemia major

21 January 2018

1 reference

12 December 2020

Growth, puberty and endocrine function in beta-thalassaemia major

1 reference

12 December 2020

Growth hormone secretion in polytransfused prepubertal patients with homozygous β-thalassemia. Effect of longterm recombinant GH (recGH) therapy

1 reference

12 December 2020

Growth and management of short stature in thalassaemia major

1 reference

12 December 2020

GH response to provocation and circulating IGF-I and IGF-binding protein-3 concentrations, the IGF-I generation test and clinical response to GH therapy in children with beta-thalassaemia

1 reference

12 December 2020

Short-term therapy with recombinant growth hormone in polytransfused thalassaemia major patients with growth deficiency

1 reference

12 December 2020

Linear growth in thalassemic children treated with intensive chelation therapy. A longitudinal study

1 reference

12 December 2020

The effect of 3 years of recombinant growth hormone therapy on glucose metabolism in short Chinese children with beta-thalassemia major.

1 reference

12 December 2020

[Growth and thalassemia]

1 reference

12 December 2020

[Growth and endocrine function in major thalassemia]

1 reference

12 December 2020

Short stature in homozygous beta-thalassaemia is due to disproportionate truncal shortening

1 reference

12 December 2020

Recombinant growth hormone treatment in short patients with thalassemia major: results after 24 and 36 months

1 reference

12 December 2020

Recombinant human growth hormone treatment in children with thalassemia major

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF03347204

1 reference

15 January 2018

1 reference

15 January 2018